Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIEL3: Rucaparib Maintenance in Ovarian Cancer
NCT01968213Phase 3Completed
- Sponsor
- pharma&
- Start
- Apr 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of rucaparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by pharma&. Started Apr 2014; status: completed.
02
Drugs
rucaparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01968213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968213.